Stock Analiz

ARS Pharmaceuticals, Inc. (SPRY) stock forecast and price target

Price $3.89 · data as of November 13, 2026

12-month price target

Average target$17.00
Upside / downside+337.0%
Analysts3
ConsensusStrong buy
Low $14.00Average $17.00High $20.00

Gold marker: average target · white marker: today’s price ($3.89)

Analyst ratings

Strong buy 1Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.87−7.5%$121M
Next fiscal year
ends December 31, 2027
$-0.86+54.2%$170M
Next quarter
ends December 31, 2026
$-0.28+34.5%$27M
Quarter after
ends March 31, 2027
$-0.34+44.3%$25M

Consensus of the analysts covering ARS Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the ARS Pharmaceuticals stock price target?

The average 12-month target from 3 analysts is $17.00, 337.0% above the current price of $3.89 Targets range from $14.00 to $20.00.

Is ARS Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is ARS Pharmaceuticals expected to earn?

Analysts expect EPS of $-1.87 for the fiscal year ending December 31, 2026 and $-0.86 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.